Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Clinical trial NCT05222516 · TERMINATED

Trial details

NCT number: NCT05222516
Sponsor: OM Pharma SA
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2021-12-20
Primary completion: 2023-07-13
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.